|[February 21, 2014]
United Health Products Inc. to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference on March 3rd
WESTBURY, N.Y. --(Business Wire)--
United Health Products, Inc. (OTCQB:
UEEC), a developer and marketer of wound care products and
technologies in the healthcare sector, announced that Douglas Beplate,
COO, will present at the 24th Annual Wall Street Analyst
Forum Institutional Investor Conference on Monday, March 3rd,
at 12:50pm EST, at The University Club of New York.
Beplate will discuss the Company's progress of the commercialization of HemoStyp®,
its proprietary gauze product, to its target markets -- including the
dental and dialysis marketplaces.
The presentation will be webcast live and slides may be accessed on the
Company's website, http://www.unitedhealthproductsinc.com/Invstors.html.
The presentation will be archived for 90 days.
Conference attendees must pre-register at: http://www.analyst-conference.com/investor-registration/.
About Wall Street Analyst Forum
The Wall Street Analyst Forum has conducted 80+ multiday/multitrack
analyst conferences in which over 2500 different NYSE/NASDAQ/AMEX/OTC
companies have presented and over 2000 different institutions have
attended in Boston, New York and London since 1989. Public companies
ranging from General Electric, Microsoft (News - Alert) Corp, Mattel, Inc., Pfizer,
Inc., Kinross Gold to Genzyme have presented. Institutions ranging from
Fidelity Management, Wellington Management, MFS Investment Management,
Pioneer Investment Management, Putnam Management have attended. Our last
three conferences have included the Chief Investment Strategist of
Morgan Stanley, Chief Economist of Deutsche Bank, Chief Investment
Strategist of UBS and Chief Investment Strategist of Oppenheimer as
keynote speakers. The WSAF was featured on CNBC, Bloomberg (News - Alert), and in the
WSJ in 1998 as the first analyst conference to webcast to analyst
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and markets
patented hemostatic gauze, for the healthcare and wound care sectors.
The product, HemoStypTM, is derived from regenerated oxidized
cellulose, which is all natural, and designed to absorb exudate/drainage
from superficial wounds and helps control bleeding. UEEC is focused on
identifying new markets and applications for its product as well as
ramping up sales in its current markets. For more on United Health
Products, Inc. visit: www.unitedhealthproductsinc.com.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995: This news release may contain forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words "believes,"
"expects," "anticipates" or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or achievements
of the Company to differ materially from those expressed or implied by
such forward-looking statements.
[ Back To TMCnet.com's Homepage ]